Acute hepatitis due to kava-kava and St John's Wort: An immun-mediated mechanism?;Akute hepatitis durch kava-kava und Johanniskraut: Immun-vermittelter mechanismus?

Deutsche Medizinische Wochenschrift

Volumn 131, Issue 21, 2006, Pages 1214-1217

  Musch, Eugen ^a   Chrissafidou, A ^a   Malek, M ^b  

^a Marien Hospital Bottrop gGmbH   (Germany)

^b Medizinische Klinik   (Germany)

Author keywords

Autoimmune hepatitis; Immunosuppressive therapy; Kava kava

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; AZATHIOPRINE; CORTISONE; HYPERICUM PERFORATUM EXTRACT; IMMUNOSUPPRESSIVE AGENT; KAVA; NEOPTERIN; TOXIN; URSODEOXYCHOLIC ACID; PLANT MEDICINAL PRODUCT;

ACUTE HEPATITIS; ADULT; ARTICLE; AUTOIMMUNE HEPATITIS; CASE REPORT; CLINICAL FEATURE; DOSE RESPONSE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERICUM PERFORATUM; IMMUNE MEDIATED INJURY; LIVER BIOPSY; LYMPHOCYTE TYPING; NUTRITIONAL ASSESSMENT; SEROLOGY; T LYMPHOCYTE ACTIVATION; TREATMENT OUTCOME; BIOPSY; BLOOD; DRUG POTENTIATION; HYPERICUM; IMMUNOLOGY; LIVER; MIDDLE AGED; PATHOLOGY; TOXIC HEPATITIS;

ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; BIOPSY; DRUG SYNERGISM; FEMALE; HEPATITIS, AUTOIMMUNE; HEPATITIS, TOXIC; HUMANS; HYPERICUM; IMMUNOSUPPRESSIVE AGENTS; KAVA; LIVER; MIDDLE AGED; PLANT PREPARATIONS;

EID: 33745513992     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-941754     Document Type: Article

References (16)

1. Anke J, Ramzan I. Kava hepatotoxicity: are we any closer to the truth? Planta Med 2004; 70: 193-196
2. Bone K. A clinical guide to blending liquid herbs: herbal formulations for the individual patient. London: Churchill Livingstone, 2003: 291-296
3. Clouatre DL. Kava kava: examining new reports of toxicity. Toxicol Lett 2004; 150: 85-96
4. Duffield AM, Jamieson DD, Lidgard RO, Duffield PH, Bourne DJ. Identification of some human urinary metabolites of the intoxicating beverage kava. J Chromatogr 1989; 475: 273-281
5. Humberston CL, Akhtar J, Krenzelok EP. Acute hepatitis induced by kava kava. Clin Toxicol 2003; 41: 109-113
6. Kamiyama T, Nouchi T, Kojima S, Murata N, Ikeda T, Sato C. Autoimmune hepatitis triggered by administration of an herbal medicine. Am J Gastroenterol 1997; 92: 703-704
7. Kaplowitz N. Hepatotoxicity of herbal remedies: insights into the intricacies of plant-animal warfare and cell death. Gastroenterology 1997; 113: 1408-1412
8. Kraft M, Spahn TW, Menzel J et al. Fulminantes Leberversagen nach Einnahme des pflanzlichen Antidepressivums Kava-Kava. Dtsch Med Wochenschr 2001; 126: 970-972
9. Mathews JM, Etheridge AS, Black SR. Inhibition of human cytochrome P450 activities by kava extract and kavalactones. Drug Metab Dispos 2002; 30: 1153-1157
10. Obach RS. Inhibition of human cytochrome P450 enzymes by constituents of St. John's Wort, an herbal preparation used in the treatment of depression. J Pharmacol Exp Ther 2000; 294: 88-95
11. Russmann S, Lauterburg BH, Helbling A. Kava Hepatotoxicity. Ann Int Med 2001; 135: 68-69
12. Schmidt M. Is kava really hepatotoxic? http://www.uni-muenster.de/Chemie/ PB/allg_Infos/Kava/page11581.html.
13. Strahl S, Ehret V, Dahm HH, Maier KP. Nekrotisierende Hepatitis nach Einnahme pflanzlicher Heilmittel. Dtsch Med Wochenschr 1998; 123: 1410-1414
14. Strassburg CP. Diagnostik und Therapie: Autoimmunhepatitis, primär biliäre Zirrhose und primär sklerosierende Cholangitis. Dtsch Med Wochenschr 2005; 130 (Suppl 5): S193-S252
15. Teschke R. Arzneimittelbedingte Lebererkrankungen. Z Gastroenterol 2002; 40: 305-326
16. Teschke R. Kava, Kava-Pyrone und toxische Leberschäden. Z Gastroenterol 2003; 41: 395-404